Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma

被引:0
|
作者
Wang, Weiwei [1 ]
He, Zhiguo [1 ]
Jia, Haowen [2 ]
Zhang, Jiansheng [1 ]
Qi, Feng [3 ]
机构
[1] Tianjin Med Univ, Baodi Clin Coll, Dept Gen Surg, 8 Guangchuan Rd, Tianjin 301800, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Airport Hosp, Dept Gen Surg, Tianjin, Peoples R China
[3] Tianjin Med Univ Gen Hosp, Dept Gen Surg, 154 Anshan Rd, Tianjin 300052, Peoples R China
基金
中国国家自然科学基金;
关键词
Cuproptosi; gene signature; hepatocellular carcinoma (HCC); prognostic analysis; immune infiltration; PYRUVATE-DEHYDROGENASE COMPLEX; CELL-DEATH; COPPER DEFICIENCY; OXIDATIVE STRESS; CANCER; DISULFIRAM; INHIBITION; DRUG; MITOCHONDRIA; EXPRESSION;
D O I
10.21037/tcr-23-1561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hepatocellular carcinoma (HCC) of which its prognostic prediction is still unclarified is a highly heterogeneous disease. Cuproptosis is a form of cell death that depends on copper regulation. Whether the cuproptosis-related genes can be the prognostic indicators of HCC is yet to be elucidated. The aim of this study is to investigate whether cuproptosis-related genes play a role in HCC and can be used as a diagnostic index to predict the occurrence of liver cancer. Methods: We downloaded HCC patients' gene expression profiles and their corresponding clinical data from a public database. To screen data, we used single factor Cox regression analysis, meanwhile, polymerase chain reaction (PCR) was used for the verification. After that, the risk score was calculated and the relationship between risk score and clinical factors was analyzed. Besides, a nomogram map was constructed for predicting the prognosis of HCC, and calibration map and decision curve analysis (DCA) map were used to test the model. Results: Compared to the high expression group of four cuproptosis-related genes, the low expression group showed better overall survival (OS) [hazard ratio (HR) =2.58; 95% confidence interval (CI): 1.72-3.89, P<0.001]. The expression of the four cuproptosis-relate genes increased in liver cancer cell lines compared to liver cell lines (P<0.05). Based on these four genes, we calculated the risk score and divided them into two groups as high-risk group and low-risk group. The risk factor map showed the high-risk group had shorter survival time and the four genes were highly expressed. The area under curve (AUC) of receiver operating characteristic (ROC) prediction curve for the first year was 0.726. Risk scores were closely related to clinical factors and immune cells. Finally, we constructed a nomogram for predicting the prognosis of HCC. Conclusions: The risk score for cuproptosis-related genes was established and involved in the construction of the nomogram, providing a new perspective on the prognosis and copper metabolism of HCC.
引用
收藏
页码:2985 / 3002
页数:18
相关论文
共 50 条
  • [31] Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
    Shi, Yuanxin
    Qiu, Peng
    Zhao, Kai
    Li, Xiangyu
    Feng, Yunxiang
    Deng, Zhengdong
    Wang, Jianming
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [32] Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer
    Hu, Yongli
    Du, Yan
    Qiu, Zhisheng
    Bai, Pengwei
    Bai, Zhaozhao
    Zhu, Chenglou
    Wang, Junhong
    Liang, Tong
    Da, Mingxu
    BIOCHEMICAL GENETICS, 2024, 62 (01) : 40 - 58
  • [33] A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer
    Lei, Lei
    Tan, Liao
    Sui, Long
    FRONTIERS IN GENETICS, 2022, 13
  • [34] Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma
    Guo, Ding-Fan
    Fan, Lin-Wei
    Zeng, Hai-Hui
    Huang, Cai-Bin
    Wu, Xin-Huan
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (02) : 739 - 764
  • [35] Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC
    Wang, Yixiu
    Zhang, Yongfa
    Wang, Longrong
    Zhang, Ning
    Xu, Weiqi
    Zhou, Jiamin
    Zhao, Yiming
    Zhu, Weiping
    Zhang, Ti
    Wang, Lu
    HEPATOLOGY INTERNATIONAL, 2022, 16 (06) : 1435 - 1447
  • [36] Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
    Lv, Yanju
    Xiao, Yajie
    Cui, Xiaoli
    Luo, Haitao
    Xu, Long
    FRONTIERS IN GENETICS, 2022, 13
  • [37] Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC
    Yixiu Wang
    Yongfa Zhang
    Longrong Wang
    Ning Zhang
    Weiqi Xu
    Jiamin Zhou
    Yiming Zhao
    Weiping Zhu
    Ti Zhang
    Lu Wang
    Hepatology International, 2022, 16 : 1435 - 1447
  • [38] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Qiongyue Zhang
    Yan Huang
    Yu Xia
    Yumeng Liu
    Jianhe Gan
    Clinical and Experimental Medicine, 2023, 23 : 2051 - 2064
  • [39] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Zhang, Qiongyue
    Huang, Yan
    Xia, Yu
    Liu, Yumeng
    Gan, Jianhe
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2051 - 2064
  • [40] Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
    Li, Shanbao
    Zhu, Zhonglin
    Lu, Jing
    Cao, Wanyue
    Song, Fangbin
    Xiao, Cao
    Zhang, Peng
    He, Zeping
    Weng, Junyong
    Xu, Junming
    FRONTIERS IN ONCOLOGY, 2023, 13